Mylan Gets Industry Aid In $50M Tax Fight At 3rd Circ.
By Daniel Ducassi · August 9, 2022, 7:58 PM EDT
A generic-drug manufacturer trade group told the Third Circuit on Monday that taxing patent litigation costs related to the expedited approval process for generic drugs would undermine the purpose of the...